Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 33 days ago
Share
Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their CART and Have Dual- or Triple-class Antiretroviral Resistance
60 patients around the world
Available in
Mexico, United States, Spain
PENTA Foundation
1
Research sites
60
Patients around the world
This study is for people with
Hiv
Requirements for the patient
To 17 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Hospital General de Mexico Dr. Eduardo Liceaga - Ciudad de México
View site
Dr. Balmis 148, Col. Doctores, Del. Cuauhtémoc, Ciudad de México
Hospital General de Mexico Dr. Eduardo Liceaga - Ciudad de México
View site
Dr. Balmis 148, Col. Doctores, Del. Cuauhtémoc, Ciudad de México
See details
Contact us
Contact us
Sponsor
PENTA Foundation
Study type
Interventional
Conditions
Hiv
Requirements
To 17 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT04648280
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent